GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $303,000 | 0.0% | 6,964 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $303,000 | -1.3% | 6,964 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $307,000 | +15.4% | 6,964 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $266,000 | -4.0% | 6,964 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $277,000 | -4.5% | 6,964 | -14.4% | 0.00% | 0.0% |
| Q1 2021 | $290,000 | +16.5% | 8,131 | +53.5% | 0.00% | 0.0% |
| Q4 2019 | $249,000 | +16.9% | 5,296 | +6.1% | 0.00% | 0.0% |
| Q3 2019 | $213,000 | -1.8% | 4,993 | -3.6% | 0.00% | 0.0% |
| Q1 2019 | $217,000 | +4.3% | 5,181 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $208,000 | -1.4% | 5,181 | -3.9% | 0.00% | 0.0% |
| Q1 2018 | $211,000 | -27.2% | 5,390 | -34.2% | 0.00% | -50.0% |
| Q4 2017 | $290,000 | -14.5% | 8,190 | -2.0% | 0.00% | 0.0% |
| Q3 2017 | $339,000 | -5.8% | 8,353 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $360,000 | +2.3% | 8,353 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $352,000 | +4.5% | 8,353 | -4.7% | 0.00% | 0.0% |
| Q4 2016 | $337,000 | -10.8% | 8,762 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $378,000 | -7.8% | 8,762 | -7.4% | 0.00% | 0.0% |
| Q2 2016 | $410,000 | +12.3% | 9,462 | +5.1% | 0.00% | 0.0% |
| Q1 2016 | $365,000 | +5.2% | 9,007 | +4.8% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | +24.8% | 8,598 | +18.9% | 0.00% | 0.0% |
| Q3 2015 | $278,000 | -17.5% | 7,233 | -10.7% | 0.00% | 0.0% |
| Q2 2015 | $337,000 | -14.0% | 8,098 | -4.7% | 0.00% | 0.0% |
| Q1 2015 | $392,000 | +16.0% | 8,498 | +7.6% | 0.00% | 0.0% |
| Q4 2014 | $338,000 | -6.9% | 7,898 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $363,000 | -25.9% | 7,898 | -13.8% | 0.00% | 0.0% |
| Q2 2014 | $490,000 | 0.0% | 9,163 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $490,000 | +0.2% | 9,163 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $489,000 | +6.8% | 9,163 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $458,000 | – | 9,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |